Characterization of breakthrough hemolysis events observed in the phase III randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria

Erstveröffentlichung

2021

Authors

Brodsky, Robert A.

de latour, Regis Peffault

Rottinghaus, Scott T.

Röth, Alexander

Risitano, Antonio M.

et al.

Wissenschaftlicher Artikel

Published in

Haematologica ; 106 (2021), 1. - S. 230-237. - ISSN 0390-6078

Link to publication

https://dx.doi.org/10.3324/haematol.2019.236877

Institutions

UKU. Institut für Transfusionsmedizin

Subject headings

[Free subject headings]: SERUM LACTATE-DEHYDROGENASE | LONG-TERM SAFETY | DISEASE | THROMBOSIS | PREGNANCY | RISK
[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record